Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Shanghai Microport Cardioflow Medtech Co. Ltd. currently has 1 pending office action in the Medical Devices & Mechanical Engineering technology area. This action is situated in 1 distinct art unit, reflecting a narrow technical scope for the company's current prosecution. The workload involves 1 distinct examiner, providing a single point of contact for the applicant's active patent matters. This suggests that the company's current innovation is highly specialized within the medical device field.
BLASS, PARIS MARIE is the busiest examiner, overseeing 1 pending office action. This single action accounts for the total number of pending office actions for the company. Because the prosecution is limited to the single examiner, the company's strategy is focused on addressing the specific examination standards of BLASS, PARIS MARIE. Practitioners should prioritize understanding the specific requirements and tendencies of this individual.
The current level of prosecution activity is targeted. With only the single art unit involved, the company avoids the complexity of navigating different technical departments. This streamlined profile within the Medical Devices & Mechanical Engineering area allows for a direct and focused effort to resolve the 1 outstanding office action and advance the company's patent applications.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BLASS, PARIS MARIE | 1 | 57.1% | +42.7% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18256889 | PROSTHETIC HEART VALVE | BLASS, PARIS MARIE | — |
| Art Unit | Apps |
|---|---|
| 3774 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18256889 | PROSTHETIC HEART VALVE | BLASS, PARIS MARIE | 3774 | §103 | Non-Final OA | — | Pending | Jun 09, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialShanghai Microport Cardioflow Medtech Co. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Paris Marie Blass has the most, with 1 of Shanghai Microport Cardioflow Medtech Co. Ltd.'s pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
